News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Seattle Biotech Acucela Inc. Sets Terms Of $162 Million Japanese IPO



2/4/2014 7:27:10 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Acucela said the underwriters of its initial public offering in Japan will sell 9.2 million shares at $17.65 apiece, raising about $143 million after expenses and discounts. Seattle biotechnology company Acucela said the underwriters of its initial public offering in Japan will sell 9.2 million shares at $17.65 apiece, raising about $143 million after expenses and discounts. The shares, which are not available to U.S. investors and won’t be traded here, have been approved for listing on the the Mothers market of the Tokyo Stock Exchange, Acucela said in a regulatory filing.

Help employers find you! Check out all the jobs and post your resume.

Read at Seattle Times
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES